Legal Psilocybin for Terminal Cancer Patients: Compassionate Access & End-of-Life Care
A podcast examining the growing movement to make psilocybin legally available to terminally ill patients — covering the history of end-of-life psilocybin research from Griffiths' 2006 mystical experience study through current compassionate access programs, and what clinical evidence supports its use in existential distress at end of life.
Content Coming Soon
This resource is being prepared and will be available shortly.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–292. https://doi.org/10.1007/s00213-006-0457-5
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.